Immunoglobulins drive efficient antigen capture by antigen presenting calls for processing and presentation on class II MHC-molecules. High affinity antibody/antigen interactions are stable at endosomal/lysosomal pH thus altering the substrate for antigen processing. We show that this can result in strong suppression of presentation of some T cell epitopes. This effect was observed when the antibody specificity was a B call surface Ig, or formed part of an immune complex. In the latter case the presence of the suppressing antibody boosts presentation of other T cell epitopes through enhanced uptake into Fc receptor bearing cells. The influence of bound antibodies on the outcome of antigen processing may influence with T cell epitopes dominate T cell responses and may change the focus of the response with time.
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T he possibility that antibody binding to antigen might influence processing and consequently, presentation of T cell epitopes on dass II MHC has often been debated. Pioneering studies by Berzofsky and Cdada and their coUeagues (1-4) indicated that antibody binding could "differentially enhance" presentation to some T cell clones either through effects on antigen uptake or on proteolytic processing. To address these questions it is essential to use a system that would allow the effects of antibody on uptake and processing to be clearly dissected and where we could analyze the effect of a single antibody specificity both as an antigen receptor on B lymphocytes and as part of an immune complex.
Earlier biochemical studies using tetanus toxin (tt)-specific human B lymphocyte clones (5) showed that high affinity antibody (Ig) binding to antigen influenced the course of antigen processing, measured by the appearance of intracellular radiolabded antigen fragments (6) . Distinct fragments were generated in B cell clones with different epitope specificity and could be modified further in the presence of additional anti-tt Fabs (6) . These and other studies where antigen/antibody complexes were digested in vitro (7, 8) provided a possible biochemical basis for the idea that the spectrum of peptides generated and subsequently displayed on class II MHC molecules might be influenced by the fine specificity of the antibodies used for antigen capture (1, 2) .
Here we demonstrate that antibody binding to tt can suppress the generation of a T cell epitope by a direct effect on processing, while at the same time enhance presentation of other epitopes via an effect on uptake.
Materials and Methods
Media and Reagents. The medium used throughout was RPMI 1640 supplemented with 2 mM L-glutamine, 1% nonessential amino acids, 1% pyruvate, 50/~g/m.1 kanamycin, 5 x 10 -s M 2-mercaptoethanol, and 10% FCS. Anti-tt antibodies (all IgG) were purified by chromatography on protein A Sepharose from concentrated culture supernatants of EBV-B cell clones, tt was a generous gift of N. Fairweather (Wellcome Biotech, Kent, UK).
B and T Cell Clones.
Three tt specific EBV-B cell clones, isolated and maintained as previously described (5) Ci/mM; Amersham Corp., Arlington Heights, IL) and the radioactivity incorporated was measured after 16 h by liquid scintillation counting. In some experiments tt and anti-tt antibodies were allowed to react in the wells of a flat-bottom microtiter plate for 1 h before the addition of APC and T cells.
T CelIEpitope Mapping. 16-mers overlapping by 6 residues and spanning the whole sequence of tt C-fragment (865-1315) were synthesized on an Abimed AMS 422 multiple peptide synthesizer using FMOC reagents.
Results and Discussion
Identification of B Cell/T Cell Incompatibilities. To identify T cell epitopes whose presentation might be influenced by bound antibodies, we first compared the ability of three tt-specific EBV-B cell clones, each recognizing a different epitope, to present tt to a panel of tt-spedfic T cell clones. T cell clones KB18 and KB3 are typical of the majority of clones studied which showed no obvious B cell preference (Fig. 1,  a and b) . However, T cell clones KB37 and KB43 showed a strikingly different result, since they were only stimulated by B cell clone 4.2 and not by 11.3 and 8.5 ( Fig. 1 c and  d ). Note that of the clones which showed no B cell preference, a range of sensitivity to antigen was observed, some with higher apparent affinity compared to KB43 and KB37, but also some with equal or lower affinity (see also Fig. 2 ).
Using overlapping peptides based on the known sequence of tt (9, 10) the epitope recognized by these clones was mapped to residues 1174-1189. Epitope 1174-1189 is found in the socalled "C fragment" domain oftt (residues 865-1315) which also includes the conformational epitopes recognized by the nonpermissive B cell clones 8.5 and 11.3. However, several other C fragment epitopes falIing on both sides of the suppressed epitope are efffciently presented by these B ceils; for example 947-967 (recognized by KB18) and 1273-1284 previously defined (11) . Thus, in spite of the very efficient antigen uptake and presentation to most T cell clones, B cell clones 11.3 and 8.5 fail to generate the epitope 1174-1189 to a level sufficient to drive T cell proliferation. At antigen concentrations which greatly exceed that needed to saturate membrane Ig (30 ltg/ml), all 3 B cell clones now presented epitope 1174-1189 equally well (data not shown) showing lOO 10o that it is only the antigen taken up on membrane Ig which fails to generate this epitope. These results indicate that B cell/T cell incompatibilities can be found in an autologous panel of human lymphocyte clones.
Suppressive Effect of Sohble Antibody on Antigen Presentation by Permissive B Cells.
To confirm that B cell Ig specificity rather than clonal differences in antigen processing (12) accounted for the preferential B ceU/T cell pairing we tested the effect of adding soluble 11.3 or 8.5 antibody to the compatible B cell/T cell combination 4.2/KB43, thus creating a situation analogous to our earlier biochemical experiments (6), where additional antibody specificities are taken up, bound to antigen, in "piggyback" fashion. As shown in Fig. 2, a and b, addition of these antibodies caused a dose dependent inhibition of presentation by clone 4.2 B cells to KB43 T cells. This suppression was very effective; such that a molar equivalent of Ig to antigen was suffcient to strongly inhibit presentation of the 1174-1189 epitope (Fig. 2) . Presentation to other T cell clones was not affected even at high concentrations of these antibodies (5 #g/m1), ruling out the possibility that they were toxic or inhibited antigen uptake (Fig.  2, c and d) . Thus these B cell/T cell incompatibilities can be directly attributed to antibody specificity and, importantly, the same specificity offered as soluble antibody can block the ability of an otherwise competent B cell to present antigen to a specific T cell clone.
Suppressive Effect of Antibody on Antigen Processing by FcR+ APC.
The suppressive effects of an antibody on processing might have a more widespread effect on the T cell response if the antibody can exert the same effect when present as part of an immune complex target to the Fc receptor bearing APC. Indeed, recent evidence indicates that priming and expansion of T cells requires professional APC such as dendritic cells or macrophages, which are more abundant than antigenspecific B cells and can deliver costimulatory signals (13) (14) (15) (16) . However, the effect of antibodies on the processing of immune complexes is complicated by the fact that they also drive antigen uptake.
Using autologous PBMC as a source of antigen presenting ceils and the same T cell clones tested above, we analyzed the effect on tt presentation of adding anti-tt monoclonal antibodies, either singly or in various combinations. Presentation of tt to the T ceU clone KB18 (tt 947-967) was enhanced by all antibodies tested singly and was boosted further by combining several specificities (Fig. 3 a) presumably due to enhanced Fc receptor-mediated antigen uptake in the presence of multiple antibodies (17) . However, T cell clone KB43 showed a strikingly different response to added antibodies (Fig. 3 b) . Some antibodies, including the "compatible" antibody 4.2, enhanced presentation, and when combined with other anti-B fragment specificities (4.2 + 12.1 + A46) presentation to KB43 was boosted still further. However, when the "incompatible" antibody 11.3 was added as a fourth specificity to the cocktail of enhancing antibodies, presentation to KB43 was virtually abolished. Only at high doses of tt, where the antibody was insufficient to complex all the antigen, could presentation to KB43 be achieved. soluble molecules in immune complexes, we have found a dear instance where antibody can suppress T ceU epitope presentation due to effects on processing (Fig. 4) .
In considering the possible implications of these results, it is interesting to note that the B cell producing the suppressing antibody can still receive "help" through presentation of other T cell epitopes which exist in a large antigen or protein complex (19), thus sustaining production of the suppressing antibody. In contrast, suppression of the T cell
Concluding Remarks
Using an experimental system where the same antibodies can be analyzed both as receptors on B lymphocytes and as epitope will be widespread through the effect of the soluble antibody acting on other B cells and on FcK + cells. Thus the suppressing effect of soluble antibody imposes an asymmetric or vectorial effect on T versus B cell responses to large antigens. However, for small antigens or peptide vaccines with few T cell epitopes a suppressive effect of antibody may eventually feed back to shut down both the T and then the B cell response. How are the 11.3 and 8.5 antibodies able to exert such a strong suppressive effect on presentation of a T cell epitope? The epitopes recognized by these antibodies are thus far only mapped to nonoverlapping conformational determinants in the tt C fragment (residues 865-1315), whereas the permissive antibody (4.2) recognizes the B fragment (residues 1-864; references 5 and 6). Since it is known that quite large fragments of antigen (>10 kD) are protected during processing by the 11.3 and 8.5 antibodies (reference 6 and P. D. Simitsek, unpublished), we suggest that these antibodies interfere with presentation by stabilizing relatively large domains, including the 1174-1189 epitope, which are not processed efllciently. Since the influence of Ig on antigen processing will eventually be overcome by further proteolytic processing, this indicates that a "window of opportunity" exists along the exogenous antigen processing pathway, within which a T cell epitope must be made available for capture by class II MHC.
Earlier studies in B cells (4) and macrophages (3) reported differential enhancement of T cell activation by different antibody specificities. In the macrophage study when mixtures of potentiating and nonpotentiating antibodies were present, potentiation of B-galactosidase presentation was dominant (3, 18) . This dearly contrasts with our results which demonstrate that in some cases bound antibody can actually shut down presentation to some T cells and, moreover, does so in a dominant fashion. The tetrameric nature of B-galactosidase is likely to complicate the enhancing (via uptake) versus the potentially suppressive (via processing) effects of antibodies. The bell-shaped curves obtained in the B-galactosidase studies (3), when T cell stimulation was plotted against antibody/ antigen ratio, might be due to enhanced uptake at low ratio when some subunits in the tetramer will be processed normally. At higher ratios, uptake will be enhanced further, but if all subunits are complexed presentation may be inhibited.
In mice immunized with intact influenza virus, the T and B cell repertoires to the hemagglutinin are often focused on the same regions of the antigen (20, 21) . However, it is known that these B cells can receive help from many helper T cells, including those specific for other viral proteins (22) . Nonetheless, it is interesting to speculate that antibody effects on processing may in some cases enhance presentation of neighboring T cell epitopes.
In general, the drive towards high affinity antibodies which do not dissociate from the antigen at endosomal pH may have a widespread influence on the outcome of antigen processing by altering the nature of the substrate for processing. We therefore suggest that prevailing antibody specifidties may influence which T cell epitopes become dominant, and as different antibody specificities emerge, may change the focus of the T cell response over time.
